Header cover image

Taiwanese (TAIEX) Drug Retail Industry Analysis

UpdatedAug 05, 2026
DataAggregated Company Financials
Companies5
  • 7D-0.3%
  • 3M-5.6%
  • 1Y-39.4%
  • YTDn/a

The Drug Retail is pretty flat in the last 7 days, but MARX Biotech has stood out, gaining 14%. Unfortunately though, the industry is down 39% over the past 12 months. Looking forward, earnings are forecast to grow by 19% annually.

Industry Valuation and Performance

Has the Taiwanese Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 05 Aug 2026NT$19.5bNT$34.3bNT$765.8m21.8x25.4x0.6x
Fri, 03 Jul 2026NT$19.7bNT$34.3bNT$765.8m21.8x25.7x0.6x
Sun, 31 May 2026NT$19.4bNT$34.3bNT$765.8m21.9x25.4x0.6x
Tue, 28 Apr 2026NT$20.8bNT$34.3bNT$687.6m19.4x30.3x0.6x
Thu, 26 Mar 2026NT$20.9bNT$34.2bNT$695.1m20.2x30x0.6x
Sat, 21 Feb 2026NT$23.0bNT$33.9bNT$712.6m21.6x32.2x0.7x
Mon, 19 Jan 2026NT$22.3bNT$33.9bNT$712.6m21.6x31.3x0.7x
Wed, 17 Dec 2025NT$21.5bNT$33.9bNT$712.6m19.9x30.2x0.6x
Fri, 14 Nov 2025NT$25.1bNT$33.8bNT$702.0m24.9x35.8x0.7x
Sun, 12 Oct 2025NT$27.1bNT$33.5bNT$755.9m27.1x35.9x0.8x
Tue, 09 Sep 2025NT$30.2bNT$33.5bNT$755.9m30.8x39.9x0.9x
Thu, 07 Aug 2025NT$31.8bNT$32.8bNT$754.7m27.6x42.1x1x
Sat, 05 Jul 2025NT$29.6bNT$32.8bNT$754.7m27.1x39.3x0.9x
Mon, 02 Jun 2025NT$32.4bNT$32.8bNT$754.7m30.2x43x1x
Wed, 30 Apr 2025NT$32.8bNT$32.3bNT$718.2m37.6x45.7x1x
Fri, 28 Mar 2025NT$36.4bNT$32.1bNT$748.3m39.4x48.6x1.1x
Sun, 23 Feb 2025NT$36.3bNT$31.8bNT$755.8m42.2x48x1.1x
Tue, 21 Jan 2025NT$32.6bNT$31.8bNT$755.8m42.7x43.1x1x
Thu, 19 Dec 2024NT$33.6bNT$31.8bNT$755.8m45.1x44.4x1.1x
Sat, 16 Nov 2024NT$36.9bNT$31.7bNT$777.8m109.6x47.5x1.2x
Mon, 14 Oct 2024NT$40.6bNT$31.0bNT$840.8m113.3x48.3x1.3x
Wed, 11 Sep 2024NT$37.2bNT$31.0bNT$840.8m110.7x44.3x1.2x
Fri, 09 Aug 2024NT$40.7bNT$30.7bNT$873.1m75.8x46.6x1.3x
Sun, 07 Jul 2024NT$44.4bNT$30.7bNT$873.1m78.8x50.8x1.4x
Tue, 04 Jun 2024NT$48.7bNT$30.7bNT$873.1m82.1x55.8x1.6x
Thu, 02 May 2024NT$49.0bNT$30.3bNT$935.7m58.5x52.3x1.6x
Sat, 30 Mar 2024NT$51.4bNT$30.2bNT$941.1m57.2x54.6x1.7x
Mon, 26 Feb 2024NT$53.1bNT$29.9bNT$964.0m59.9x55.1x1.8x
Wed, 24 Jan 2024NT$53.0bNT$29.9bNT$964.0m64.9x54.9x1.8x
Fri, 22 Dec 2023NT$52.6bNT$26.8bNT$949.0m57.6x55.5x2x
Sun, 19 Nov 2023NT$52.1bNT$26.8bNT$949.0m57.7x54.9x1.9x
Tue, 17 Oct 2023NT$55.4bNT$26.3bNT$1.0b46.2x54.3x2.1x
Thu, 14 Sep 2023NT$53.4bNT$26.3bNT$1.0b46.2x52.3x2x
Sat, 12 Aug 2023NT$57.3bNT$26.8bNT$1.2b24.8x48.4x2.1x
Price to Earnings Ratio

48.4x


Total Market Cap: NT$57.3bTotal Earnings: NT$1.2bTotal Revenue: NT$26.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Drug Retail Industry Price to Earnings3Y Average 43.9x202420252026
Current Industry PE
  • Investors are pessimistic on the Taiwanese Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 25.4x which is lower than its 3-year average PE of 43.9x.
  • The 3-year average PS ratio of 1.2x is higher than the industry's current PS ratio of 0.57x.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have declined 14% per year over the last three years.
  • Meanwhile revenues for these companies have grown 8.6% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Taiwanese Drug Retail compare with similar industries?

TW Market4.34%
Consumer Staples-3.58%
Food and Staples Retail-5.17%
Drug Retail-0.28%
Big Box Super Stores0%0
Food Distributors-0.25%
Food Retail-5.66%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
7731 MARX BiotechNT$4.8614.9%
+NT$328.8m
3.2%PE59.1x
4175 MedFirst Healthcare ServicesNT$50.001.0%
+NT$21.2m
-20.4%PE16.3x
6844 Norbel BabyNT$60.600.8%
+NT$18.7m
-38.9%PE23.3x
6929 We Can MedicinesNT$23.401.7%
+NT$18.0m
-26.3%PS0.3x

Latest News